Overview of FDA Recalled Drug
Bextra, also known as valdecoxib, is a prescription medicine known as a COX-2 Inhibitor. Like Vioxx and Celebrex, it supposedly lessen the pain of inflammation and fever without causing stomach irritation common to aspirin and other NSAIDs (Non-Steroidal Anti-Inflammatory Drugs). Pharmaceutical corporation Pfizer released Bextra in 2001, and prescription sales soon rose to 3.2 billion dollars.
Bextra is used to take care of an assortment of different conditions, including arthritis, menstrual cramps, and other types of chronic inflammation or low level pain. Pfizer discovered in 2002 that Bextra offered an elevated risk of serious skin irritation during the beginning stages of treatment. Also, during a complicated heart procedure called coronary artery bypass graft, certain patients who had also taken Bextra developed serious heart problems. Bextra also created a heightened risk of Steven-Johnsons's Syndrome, a potentially fatal skin condition resulting in infection and inflammation, and Toxic Epidermal Necrolysis, which creates infected skin to flake off and die. In addition, it was originally believed that Bextra, like its sister drug Celebrex, might pose the same heightened risk of stroke and heart attack, and the FDA ordered more examinations to investigate this possibility. Later, in April 2005, the FDA asked Pfizer to remove Bextra from the market because the side effects proved too dangerous for public consumption.
Victims of pharmaceutical shortsightedness have a right to be compensated. A knowledgeable attorney is the key to getting you the settlement you deserve. Just as important as your physical recovery, your financial recovery depends on the action you decide to take. Hesitating one day may prevent you from taking the legal action necessary to recover your losses. Contact a lawyer today!
To learn more about Bextra please visit our informational website at http://www.resource4bextrainfo.com
This article can be freely republished granted that this resource box is included and all links remain intact.
Latest News
BioImagene CEO, Dr. Ajit Singh, Speaks On Enabling Personalized ... MarketWatch - Digital pathology, a key enabler for personalized medicine, will aid clinicians in managing and interpreting data from a whole new set of diagnostic tests ... Aperio Introduces SecondSlide(TM) Digital Slide Sharing Network |
 eFluxMedia | Medicine for the Job Market New York Times, United States - By JONATHAN GRUBER A CENTRAL feature of Barack Obama’s presidential campaign was an aggressive plan to expand health insurance coverage by subsidizing ... Reform or bust New Report Shows Slower Premium Growth, But Increasing Pressure to ... Health Corps |
 eFluxMedia | American College of Surgeons Comments on Institute of Medicine ... MarketWatch - CHICAGO, Dec 03, 2008 /PRNewswire-USNewswire via COMTEX/ -- The American College of Surgeons (ACS) today recognized the Institute of Medicine (IOM) for its ... Report urges more sleep for medical residents Medical Residents Must Sleep After 16 Hours, Experts Urge Expert Panel Seeks Changes in Training of Medical Residents |
Research and Markets: 2008 Integrative Medicine and Dietary ... MarketWatch - In this 32-page issue, we offer a breakdown of 2007 US Complementary and Alternative Medicine sales data and provides a detailed analysis of new integrative ... |
 Afrik.com | 34 Nigerian Children Dead From Tainted Medicine Voice of America - By VOA News Nigerian health officials say they are flying in doses of an antidote for a poisoned teething medicine that has now killed 34 infants. ... 'Toxic' syrup kills Nigerian babies Teething mixture kills more Nigerian babies Nigeria infant drug toll hits 34, antidote flown in |
Research database from the US Library of Medicine The Plain Dealer - cleveland.com, OH - Search PubMed, Clinicaltrials.gov, the CDC and a dozen other medical sites - all at once. AP MEDICAL VIDEO by Michael O'Malley and Joan Mazzolini/Plain ... |
A New Index of Preventive Medicine Companies Motley Fool - The accompanying table [click to enlarge] presents statistics and the top 15 rated companies in the ETF Innovators [ETFI] Preventive Medicine Index. ... |
NIGERIA: Jos displaced grapple with food, water, medicine shortages IRINnews.org, NY - JOS, 4 December 2008 (IRIN) - Water, medicine and food supplies are running low for an estimated 10000 people displaced by violence in Jos, northern Nigeria ... |
 Canada.com | "Rogue" stem cell clinics exploit hope: report Reuters - "The direct-to-consumer portrayal of stem cell medicine is optimistic and unsupported by published evidence," Timothy Caulfield of the University of Alberta ... Scientists warn of “rogue” online stem cell clinics Internet stem-cell clinics 'exploiting' MS and Parkinson's patients The International Society for Stem Cell Research Releases New ... |
 TheMedGuru | Extended Drug Therapy for Hepatitis Is Challenged New York Times, United States - “This is a treatment that should not be done,” said Dr. Howard Worman, professor of medicine at Columbia University College of Physicians and Surgeons, ... Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose ... Treatment for advanced hepatitis C doesn't work, researchers find Hepatitis C Therapy Useless for Some |
Resources
-
Sorry Currently Unavailable